Everus Construction Group Statistics
Total Valuation
ECG has a market cap or net worth of $6.17 billion. The enterprise value is $6.38 billion.
| Market Cap | 6.17B |
| Enterprise Value | 6.38B |
Important Dates
The last earnings date was Tuesday, February 24, 2026, after market close.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ECG has 51.01 million shares outstanding. The number of shares has increased by 0.10% in one year.
| Current Share Class | 51.01M |
| Shares Outstanding | 51.01M |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 86.74% |
| Float | 50.85M |
Valuation Ratios
The trailing PE ratio is 30.60 and the forward PE ratio is 29.02.
| PE Ratio | 30.60 |
| Forward PE | 29.02 |
| PS Ratio | 1.65 |
| Forward PS | 1.58 |
| PB Ratio | 9.79 |
| P/TBV Ratio | 12.67 |
| P/FCF Ratio | 68.50 |
| P/OCF Ratio | 39.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.75, with an EV/FCF ratio of 70.93.
| EV / Earnings | 31.64 |
| EV / Sales | 1.70 |
| EV / EBITDA | 21.75 |
| EV / EBIT | 24.12 |
| EV / FCF | 70.93 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.59.
| Current Ratio | 1.76 |
| Quick Ratio | 1.60 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 4.13 |
| Interest Coverage | 12.34 |
Financial Efficiency
Return on equity (ROE) is 38.34% and return on invested capital (ROIC) is 23.45%.
| Return on Equity (ROE) | 38.34% |
| Return on Assets (ROA) | 10.97% |
| Return on Invested Capital (ROIC) | 23.45% |
| Return on Capital Employed (ROCE) | 26.67% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $430,619 |
| Profits Per Employee | $23,192 |
| Employee Count | 8,700 |
| Asset Turnover | 2.48 |
| Inventory Turnover | 73.97 |
Taxes
In the past 12 months, ECG has paid $72.31 million in taxes.
| Income Tax | 72.31M |
| Effective Tax Rate | 26.38% |
Stock Price Statistics
The stock price has increased by +168.60% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +168.60% |
| 50-Day Moving Average | 94.67 |
| 200-Day Moving Average | 81.06 |
| Relative Strength Index (RSI) | 65.44 |
| Average Volume (20 Days) | 799,516 |
Short Selling Information
The latest short interest is 2.11 million, so 4.13% of the outstanding shares have been sold short.
| Short Interest | 2.11M |
| Short Previous Month | 1.81M |
| Short % of Shares Out | 4.13% |
| Short % of Float | 4.15% |
| Short Ratio (days to cover) | 3.04 |
Income Statement
In the last 12 months, ECG had revenue of $3.75 billion and earned $201.77 million in profits. Earnings per share was $3.95.
| Revenue | 3.75B |
| Gross Profit | 454.09M |
| Operating Income | 264.75M |
| Pretax Income | 274.08M |
| Net Income | 201.77M |
| EBITDA | 293.55M |
| EBIT | 264.75M |
| Earnings Per Share (EPS) | $3.95 |
Balance Sheet
The company has $152.67 million in cash and $372.09 million in debt, with a net cash position of -$219.42 million or -$4.30 per share.
| Cash & Cash Equivalents | 152.67M |
| Total Debt | 372.09M |
| Net Cash | -219.42M |
| Net Cash Per Share | -$4.30 |
| Equity (Book Value) | 629.82M |
| Book Value Per Share | 12.35 |
| Working Capital | 560.19M |
Cash Flow
In the last 12 months, operating cash flow was $156.85 million and capital expenditures -$66.84 million, giving a free cash flow of $90.01 million.
| Operating Cash Flow | 156.85M |
| Capital Expenditures | -66.84M |
| Free Cash Flow | 90.01M |
| FCF Per Share | $1.76 |
Margins
Gross margin is 12.12%, with operating and profit margins of 7.07% and 5.39%.
| Gross Margin | 12.12% |
| Operating Margin | 7.07% |
| Pretax Margin | 7.32% |
| Profit Margin | 5.39% |
| EBITDA Margin | 7.84% |
| EBIT Margin | 7.07% |
| FCF Margin | 2.40% |
Dividends & Yields
ECG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.10% |
| Shareholder Yield | -0.10% |
| Earnings Yield | 3.27% |
| FCF Yield | 1.46% |
Analyst Forecast
The average price target for ECG is $101.00, which is -16.44% lower than the current price. The consensus rating is "Buy".
| Price Target | $101.00 |
| Price Target Difference | -16.44% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 4.89% |
| EPS Growth Forecast (5Y) | 7.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ECG has an Altman Z-Score of 5.33 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.33 |
| Piotroski F-Score | 6 |